Linked Data API

Show Search Form

Search Results

1436062
registered interest false more like this
date less than 2022-02-25more like thismore than 2022-02-25
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Abortion: Drugs more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what assessment they have made of the impact of ending the home use of mifepristone on (1) waiting times, (2) workforce pressures, and (3) the long-term sustainability, of abortion services. more like this
tabling member printed
Baroness Bennett of Manor Castle more like this
uin HL6438 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-03-07more like thismore than 2022-03-07
answer text <p>Given current pressures on the sector, the Government has provided an extended period for services to plan for the return of face-to-face treatments. We will continue to work with NHS England and NHS Improvement, the Care Quality Commission and abortion providers to ensure a safe and reliable return to face-to-face services.</p><p>We are developing a new Sexual and Reproductive Health Strategy which will set out plans to improve reproductive health outcomes and wellbeing. Whilst issues relating to abortion legislation will not be in scope of the Strategy, ensuring the sustainability of accessible and high quality abortion services for women will be a priority.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-03-07T15:22:47.327Zmore like thismore than 2022-03-07T15:22:47.327Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
4719
label Biography information for Baroness Bennett of Manor Castle remove filter